โ Back to Home
๐ Glossary of Terms
Medical terminology explained in plain language
A
- Adjuvant therapy
- Treatment given after the primary treatment (surgery) to kill remaining cancer cells. In GBM, this is the TMZ cycles after chemoradiation.
- Anaplastic
- Rapidly growing, aggressive. Anaplastic astrocytoma is grade 3, one step below GBM (grade 4).
- Angiogenesis
- Formation of new blood vessels. Tumors need blood vessels to grow. Anti-angiogenic drugs (like Avastin) try to starve tumors by blocking this.
- Apoptosis
- Programmed cell death. Normal cells die when damaged; cancer cells avoid this. Many treatments try to trigger apoptosis in cancer cells.
- Astrocyte
- A type of brain cell (glial cell) that supports neurons. GBM arises from these cells.
B
- BBB (Blood-Brain Barrier)
- A protective barrier that prevents most substances from entering the brain from the bloodstream. Major obstacle to treating brain tumors โ most drugs can't cross it.
- Bevacizumab (Avastin)
- Anti-angiogenic drug that blocks VEGF. FDA approved for recurrent GBM. Improves symptoms but doesn't extend survival.
- Biopsy
- Removing a small tissue sample to examine under microscope. Used to diagnose tumor type when full removal isn't possible.
C
- CAR-T therapy
- Chimeric Antigen Receptor T-cell therapy. Patient's immune cells are modified to attack cancer. Promising for GBM but still experimental.
- Concurrent therapy
- Treatments given at the same time. In Stupp protocol, radiation and TMZ are given concurrently for 6 weeks.
- Craniotomy
- Surgery where part of the skull is removed to access the brain. Standard approach for GBM surgery.
D
- Dexamethasone (Decadron)
- Steroid medication used to reduce brain swelling (edema). Very effective but has significant side effects.
- Diffuse
- Spread throughout, not contained. GBM is "diffuse" meaning cells spread into surrounding brain tissue, making complete removal impossible.
E
- Edema
- Swelling. Brain edema around tumors causes symptoms like headaches, confusion, weakness.
- EGFR (Epidermal Growth Factor Receptor)
- A protein often overactive in GBM, promoting cell growth. Some treatments target EGFR.
- Eloquent area
- Brain regions controlling critical functions (speech, movement, vision). Tumors in eloquent areas are harder to remove safely.
G
- GBM (Glioblastoma)
- Glioblastoma multiforme. The most aggressive primary brain tumor. Grade 4. Median survival 15-18 months with treatment.
- Glioma
- Tumor arising from glial cells (support cells of the brain). Includes astrocytoma, oligodendroglioma, and GBM.
- Grade
- How aggressive a tumor is. Grade 1-2 are low-grade (slow). Grade 3-4 are high-grade (aggressive). GBM is always grade 4.
- Gross Total Resection (GTR)
- Complete visible removal of tumor on MRI. Best surgical outcome. Associated with longer survival.
I
- IDH (Isocitrate Dehydrogenase)
- An enzyme. IDH mutation = better prognosis. Since 2021, IDH-mutant grade 4 tumors are NOT called GBM anymore (they're "astrocytoma grade 4"). True GBM is IDH-wildtype.
- Immunotherapy
- Treatments that help the immune system fight cancer. Includes checkpoint inhibitors, vaccines, CAR-T. Still largely experimental for GBM.
- Infiltrating/Invasive
- Growing into surrounding tissue. GBM is highly infiltrative โ cells spread beyond the visible tumor, making cure impossible with surgery alone.
K
- KPS (Karnofsky Performance Status)
- Scale from 0-100 measuring how well patient functions. 100 = normal. 70+ = able to care for self. Used to determine treatment eligibility.
- Ketogenic diet
- Very low carbohydrate, high fat diet that puts body in ketosis. Being studied for GBM because tumors depend on glucose.
M
- MGMT (O6-methylguanine-DNA methyltransferase)
- DNA repair enzyme. If MGMT gene is methylated (silenced), tumor can't repair TMZ damage = better response to chemo. If unmethylated = poor TMZ response.
- MRI (Magnetic Resonance Imaging)
- Primary imaging for brain tumors. Shows tumor location, size, and changes over time.
- Multifocal
- Multiple separate tumors. Worse prognosis than single tumor.
N
- Necrosis
- Dead tissue. GBM characteristically has necrosis at center. "Radiation necrosis" = brain tissue death from radiation (can mimic recurrence on MRI).
- Neuro-oncologist
- Cancer specialist focused on brain and spine tumors. Should be part of your care team.
O
- Oncolytic virus
- Viruses engineered to infect and kill cancer cells. PVS-RIPO (polio virus) and DNX-2401 are in trials for GBM.
- Optune (TTFields)
- Tumor Treating Fields. Device worn on head that delivers electric fields to disrupt cancer cell division. FDA approved for GBM.
P
- Palliative care
- Care focused on quality of life, symptom management, and support. NOT the same as hospice. Can be provided alongside active treatment.
- Progression
- Tumor growth or spread. "Progression-free survival" = time before tumor grows again.
- Pseudoprogression
- MRI looks worse after radiation, but it's not actual tumor growth โ it's inflammation/treatment effect. Usually happens 1-3 months after radiation.
R
- Radiation (RT)
- High-energy beams that damage DNA, killing cancer cells. Standard for GBM: 60 Gy in 30 fractions over 6 weeks.
- Recurrence
- Tumor coming back after treatment. Nearly universal in GBM.
- Resection
- Surgical removal. "Extent of resection" = how much was removed (GTR, subtotal, biopsy only).
S
- Stereotactic
- Using 3D coordinates for precise targeting. "Stereotactic radiosurgery" = highly focused single-dose radiation.
- Stupp Protocol
- Standard treatment regimen for GBM: surgery โ 6 weeks radiation with daily TMZ โ TMZ cycles for 6-12 months. Named after Dr. Roger Stupp.
T
- Temozolomide (TMZ, Temodar)
- Oral chemotherapy, standard of care for GBM. Works by damaging tumor DNA. Most effective if MGMT methylated.
- TTFields (Tumor Treating Fields)
- See Optune. Electric fields that interfere with cell division. Adds ~5 months median survival.
V
- VEGF (Vascular Endothelial Growth Factor)
- Protein that stimulates blood vessel growth. Bevacizumab blocks VEGF.
W
- WHO Classification
- World Health Organization brain tumor classification. Updated in 2021 โ now requires molecular markers (IDH, etc.) not just appearance.
- Wildtype
- Normal, non-mutated. "IDH-wildtype" = no IDH mutation = true GBM = worse prognosis.